Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Docetaxel Trihydrate | Docetaxel is a cytotoxic agent, which is related to its ability to promote the formation of microtubule bundles and induce sustained mitotic arrest, followed by apoptosis of mitotically arrested cells or permanent mitotic block. Synonyms: 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete Benzenepropanoic Acid Deriv.; [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic Acid Trihydrate; (αR,βS)-(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic Acid Trihydrate; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel trihydrate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate--water (1/3); Docetaxel (USP) RP56976 (NSC 628503) Trihydrate; RP 56976 (NSC-628503) Trihydrate; RP-56976 (NSC628503) Trihydrate. Grade: 98%. CAS No. 148408-66-6. |  |
| Docetaxel Trihydrate | Docetaxel Trihydrate (RP-56976 Trihydrate) is an antineoplastic agent and inhibits microtubule depolymerization with an IC 50 value of 0.2 μM [1]. Docetaxel Trihydrate is a semisynthetic analog of taxol and attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel Trihydrate arrests the cell cycle at G2/M and leads to cell apoptosis [1] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RP-56976 Trihydrate. CAS No. 148408-66-6. Pack Sizes: 10 mM * 1 mL; 100 mg. Product ID: HY-B0011A. |  |
| 10-Acetyl docetaxel | 10-Acetyl docetaxel. Group: Biochemicals. Alternative Names: Docetaxel ( (Trihydrate). Grades: Highly Purified. CAS No. 125354-16-7. Pack Sizes: 10g, 25g, 50g, 100g, 250g. Molecular Formula: C45H55NO15. US Biological Life Sciences. |  Worldwide |
| Docetaxel | Docetaxel, also called Taxoltere metro, a semisynthetic side-chain analogue of taxol differing at two positions in its chemical structure, is an inhibitior of microtubule disassembly (IC50 = 0.2 μM). And it inhibits cell replication (IC50 = 0.13 μM). Uses: Antitumor. Synonyms: docetaxel; docetaxel anhydrous; docetaxel hydrate; docetaxel trihydrate; docetaxol; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; RP-56976; Taxoltere metro; 114977-28-5. Grade: 98%~102%. CAS No. 114977-28-5. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| 10-epi-Docetaxel | 10-epi-Docetaxel is an isomer of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: [(1S,2S,3R,4S,7R,9S,10S,12S,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate; (2α,5β,7β,10α,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6S,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| 2'-Ac-Docetaxel | 2'-Ac-Docetaxel is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2'-O-Acetyldocetaxel; Docetaxel Impurity 57; (2α,5β,7β,10β,13α)-4-(acetyloxy)-13-({(2R,3S)-2-(acetyloxy)-3-[(tert-butoxycarbonyl)amino]-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; Benzenepropanoic acid, α-(acetyloxy)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; 2'-acetyldocetaxel. CAS No. 151509-27-2. Molecular formula: C45H55NO15. Mole weight: 849.92. | |
| 2-Desbenzoyl-2-pentonyl Docetaxel | 2-Desbenzoyl-2-pentonyl Docetaxel is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: (2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl valerate; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-12-[(1-oxopentyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-. Molecular formula: C41H57NO14. Mole weight: 787.89. | |
| 2-Desbenzoyl-2-tiglyl Docetaxel | Docetaxel injection impurity A. Group: Biochemicals. Alternative Names: (2b,5b,7a,10b,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl (2E)-2-Methylbut-2-enoate; Docetaxel Impurity A. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 2'-Epi docetaxel | 2'-Epi docetaxel. Group: Biochemicals. Alternative Names: (a-S, b-S) -b- [ [ (1, 1-Dimethylethoxy) carbonyl] amino] -a-hydroxy Benzene propanoic acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 6, 11-trihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl ester; 2'-epi-taxotere. Grades: Highly Purified. CAS No. 133577-33-0. Pack Sizes: 1mg, 2mg, 5mg, 10mg. Molecular Formula: C43H53NO14. US Biological Life Sciences. | Worldwide |
| 2-Epi Docetaxel | An impurity of Docetaxel. Group: Biochemicals. Alternative Names: (αS, βS)- β - [ [ (1, 1-Dimethylethoxy) carbonyl] amino] - α -hydroxy Benzene propanoic Acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 6, 11-trihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester; 2'-epi-Taxotere. Grades: Highly Purified. CAS No. 133577-33-0. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| 2-Epi Docetaxel Impurity | Docetaxel impurity. Synonyms: (αS,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H. Grade: > 95%. CAS No. 133577-33-0. Molecular formula: C43H53NO14. Mole weight: 807.9. | |
| 2R,3R-Docetaxel | 2R,3R-Docetaxel is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete Benzenepropanoic Acid Derivative; R-Erythro-taxotere; 3'-epi-docetaxel; 3'(S)-Docetaxel; Paclitaxel Impurity 62; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βR)-; Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βR*),11α,12α,12aα,12bα]]-. Grade: ≥90%. CAS No. 133577-32-9. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| 2'-Triethylsilyldocetaxel | Used in the preparation of ester-linked docetaxel-monosaccharide conjugates. Group: Biochemicals. Alternative Names: (αR, βS)- β -[[ (1, 1-Dimethylethoxy) carbonyl]amino]-α -[ (triethylsilyl) oxy]-benzenepropanoic Acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 6, 11-trihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester. Grades: Highly Purified. CAS No. 162871-12-7. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| 7-epi-10-Oxo-10-deacetyl Baccatin III | 7-epi-10-Oxo-10-deacetyl Baccatin III is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: (2aR,4R,4aS,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,9,10,11,12,12a,12b-decahydro-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-5,6-dione; 10-Deacetyl-10-oxo-baccatin V; 10-Dehydrobaccatin V; Docetaxel Impurity 20; 7-epi-10-oxo-10-DAB. Grade: 97%. CAS No. 151636-94-1. Molecular formula: C29H34O10. Mole weight: 542.57. | |
| 7-Epi Docetaxel | An isomer of Docetaxel. Docetaxel injection. Group: Biochemicals. Alternative Names: (2b,5b,7a,10b,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl Benzoate; 7-Epidocetaxel; 7-Epitaxotere. Grades: Highly Purified. CAS No. 153381-68-1. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cabazitaxel intermediate | Cabazitaxel intermediate is extracted from the barks of Taxus yunnanensis. Synonyms: 5-[(2α,5β,7β,10β,13α)-4-Acetoxy-2-(benzoyloxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-13-yl] 3-(2-methyl-2-propanyl) (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate; 3,5-Oxazolidinedicarboxylic acid, 2-(4-methoxyphenyl)-4-phenyl-, 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl] 3-(1,1-dimethylethyl) ester, (4S,5R)-; Cabazitaxel N-2; Docetaxel Impurity 62. Grade: 97.0%. CAS No. 1354900-65-4. Molecular formula: C51H59NO15. Mole weight: 926.02. | |
| Docetaxel | Docetaxel (RP-56976) is a microtubule depolymerization inhibitor, with an IC50 of 0.2 μM. Docetaxel attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity. Uses: Designed for use in research and industrial production. Additional or Alternative Names: TAXOTERE;n-debenzoyl-n-tert-butoxycarbonyl-10-deacetyl taxol;)benz(1,2-b)oxet-9-ylester,(2ar-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alph;-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydr;benzenepropanoicacid,beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy;beta-s*),11-alpha,12-alpha,12a-alpha,12b-alpha))-a-r;o-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4;rp56976. Product Category: Inhibitors. Appearance: Solid. CAS No. 114977-28-5. Molecular formula: C43H53NO14. Mole weight: 807.88. Purity: 0.9942. Canonical SMILES: O=C(OC(C)(C)C)N[C@@H](C1=CC=CC=C1)[C@H](C(O[C@@H]2C(C)=C([C@@H](O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@@]4([H])C[C@@H]3O)([H])[C@@H]5OC(C6=CC=CC=C6)=O)=O)C(C)(C)[C@@]5(O)C2)=O)O. Product ID: ACM114977285-1. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Docetaxel EP Impurity A | Docetaxel EP Impurity A is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2-O-desbenzoyl-2-O-tiglyldocetaxel; 5β,20-epoxy-1,7β,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] 2-[(2E)-2-methylbut-2-enoate]. CAS No. 1887057-05-7. Molecular formula: C41H55NO14. Mole weight: 785.87. | |
| Docetaxel EP Impurity C | Docetaxel EP Impurity C is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 4-epi-Docetaxel (USP); 4-Epidocetaxel; 7-Epidocetaxel; 7-Epitaxotere; 5β,20-epoxy-1,7α,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate]. Grade: >98%. CAS No. 153381-68-1. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| Docetaxel EP Impurity C | Docetaxel EP Impurity C. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7-epi-Docetaxel; (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 153381-68-1. Molecular formula: C43H53NO14. Mole weight: 807.88. Catalog: APB153381681. |  |
| Docetaxel Hydrate | Docetaxel Hydrate, a semisynthetic derivative of Paclitaxel, is used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Uses: A semisynthetic derivative of paclitaxel. an antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. an antineoplastic. Synonyms: (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester Hydrate; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Hydrate; RP 56976 Hydrate; Taxotere Hydrate. CAS No. 700367-34-6. Molecular formula: C43H53NO14.xH2O. Mole weight: 807.88 (anhydrous). | |
| Docetaxel Hydroxy tert-Butylcarbamate | Docetaxel Hydroxy tert-Butylcarbamate is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: Docetaxel Metabolite M2; RPR-104952; Benzenepropanoic acid, α-hydroxy-β-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(1-hydroxy-2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate. Grade: ≥95%. CAS No. 154044-57-2. Molecular formula: C43H53NO15. Mole weight: 823.88. | |
| Docetaxel Impurity 11 | Docetaxel Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-Debenzoyl-2-Pentenoyl Docetaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl pent-4-enoate. CAS No. 1412898-66-8. Molecular formula: C41H55NO14. Mole weight: 785.87. Catalog: APB1412898668. | |
| Docetaxel Impurity 17 | Docetaxel Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2aR,4R,4aS,9S,11S,12S,12aR,12bS)-12b-acetoxy-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-5,6-dioxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 151636-94-1. Molecular formula: C29H34O10. Mole weight: 542.57. Catalog: APB151636941. | |
| Docetaxel Impurity 2 | Docetaxel Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 133524-69-3. Molecular formula: C38H45NO12. Mole weight: 707.76. Catalog: APB133524693. | |
| Docetaxel Metabolite M4 | Docetaxel Metabolite M4 is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: RPR 104943; (2α,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 3-Oxazolidinepropanoic acid, α-hydroxy-5,5-dimethyl-2,4-dioxo-β-phenyl-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-. Grade: 95%. CAS No. 157067-34-0. Molecular formula: C43H49NO15. Mole weight: 819.852. | |
| Hexanoyl Docetaxel Metabolite M4 | Hexanoyl Docetaxel Metabolite M4 is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 3-Oxazolidinepropanoic acid, 5,5-dimethyl-2,4-dioxo-α-[(1-oxohexyl)oxy]-β-phenyl-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2α,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2-(hexanoyloxy)-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate. Molecular formula: C49H59NO16. Mole weight: 917.99. | |
| Hexanoyl Docetaxel Metabolites M1 and M3 (Mixture of Diastereomers) | Hexanoyl Docetaxel Metabolites M1 and M3 (Mixture of Diastereomers) are metabolites of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 3-Oxazolidinepropanoic acid, 4-hydroxy-5,5-dimethyl-2-oxo-α-[(1-oxohexyl)oxy]-β-phenyl-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2α,5β,7β,10β,13α)-4-Acetoxy-13-{[(2R,3S)-2-(hexanoyloxy)-3-(4-hydroxy-5,5-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate. Molecular formula: C49H61NO16. Mole weight: 920.00. | |
Our database is helping our users find suppliers everyday.
